| 10780073 |
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
Julie Marie Hicks, Fredrik P. Marmsater, Qian Zhao |
2020-09-22 |
| 10766878 |
Sulfonylcycloalkyl carboxamide compounds |
Baihua Hu, Vishal Verma, Matthew Volgraf, Anthony A. Estrada |
2020-09-08 |
| 10759783 |
Biaryl inhibitors of Bruton'S tyrosine kinase |
Brian T. Hopkins, Bin Ma, Timothy Chan, Lihong Sun, Lei Zhang +3 more |
2020-09-01 |
| 10709692 |
Isoxazolidine derived inhibitors of receptor interacting protein kinase 1 (RIPK1) |
Giorgio Bonanomi, Anthony A. Estrada, Jianwen A. Feng, Brian M. Fox, Colin Philip Leslie +6 more |
2020-07-14 |
| 10675367 |
Deuterated compounds and uses thereof |
Jan Marik, Simon Williams |
2020-06-09 |
| 10604535 |
Compounds, compositions and methods |
Anthony A. Estrada, Jianwen A. Feng, Brian M. Fox, Colin Philip Leslie, Alfonso Pozzan +2 more |
2020-03-31 |
| 10597383 |
Bicyclic proline compounds |
Vishal Verma, Daniel Shore, Matthew Volgraf, Anthony A. Estrada |
2020-03-24 |
| 10590114 |
Compounds, compositions, and methods |
Anthony A. Estrada, Jianwen A. Feng, Zachary K. Sweeney, Javier de Vicente Fidalgo |
2020-03-17 |
| 10577367 |
IRAK4 inhibiting agents |
Timothy Chan, Kevin M. Guckian, Tracy J. Jenkins, Jermaine Thomas, Jeffery Vessels +5 more |
2020-03-03 |
| RE47848 |
Biheteroaryl compounds and uses thereof |
Anthony Estrada, Alan G. Olivero, Snahel Patel, Michael Siu, Malcolm Huestis +1 more |
2020-02-11 |
